Robert B Abramovitch

Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Venues

Antimicrobial agents and chemotherapy

Scientific reports

Future medicinal chemistry

mBio

Michigan State University

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Michigan State University

United States

Associate Professor :: Microbiology and Molecular Genetics

Michigan State University

United States

Assistant Professor :: Microbiology and Molecular Genetics

Cornell University

United States

Postdoctoral Fellow :: Microbiology and Immunology

Education History

Cornell University

United States

PHD :: Plant Pathology

University of British Columbia

Canada

BSC :: Microbiology and Immunology

Publications

Ifeanyichukwu E Eke, John T Williams, Elizabeth R Haiderer, Veronica J Albrecht, Heather M Murdoch, Bassel J Abdalla, Robert B Abramovitch
Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacy. Antimicrobial agents and chemotherapy (2023)
John T Williams, Robert B Abramovitch
Molecular Mechanisms of MmpL3 Function and Inhibition. Microbial drug resistance (Larchmont, N.Y.) (2023)
John T Williams, Jacob J Baker, Huiqing Zheng, Shelby J Dechow, Jared Fallon, Megan Murto, Veronica J Albrecht, Haleigh N Gilliland, Andrew J Olive, Robert B Abramovitch
A genetic selection for Mycobacterium smegmatis mutants tolerant to killing by sodium citrate defines a combined role for cation homeostasis and osmotic stress in cell death. mSphere (2023)
John T Williams, Matthew Giletto, Elizabeth R Haiderer, Bilal Aleiwi, Teresa Krieger-Burke, Edmund Ellsworth, Robert B Abramovitch
The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection. Microbiology spectrum (2023)
Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, Charlotte Avanzi, Crystal J Wiersma, John T Williams, Benjamin K Johnson, Matthew D Zimmerman, Nicholas Whittel, Bhanupriya Angala, Han Wang, Victoria Jones, Veronique Anne Dartois, Vinicius C N de Moura, Mercedes Gonzalez-Juarrero, Camron Pearce, Alan R Schenkel, Kenneth C Malcolm, Jerry A Nick, Susan A Charman, Timothy N C Wells, Brendan K Podell, Jonathan L Vennerstrom, Diane J Ordway, Robert B Abramovitch, Mary Jackson
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus . Science translational medicine 14 (633) (2022)
Robert B Abramovitch
Targeting tuberculosis - an interview with Robert Abramovitch. Future medicinal chemistry 14 (14) (2022)
Shelby J Dechow, Jacob J Baker, Megan Murto, Robert B Abramovitch
<i>ppe51</i> Variants Enable Growth of Mycobacterium tuberculosis at Acidic pH by Selectively Promoting Glycerol Uptake. Journal of bacteriology 204 (11) (2022)
Huiqing Zheng, Robert B Abramovitch
Inhibiting DosRST as a new approach to tuberculosis therapy. Future medicinal chemistry 12 (5) (2020)
Kevin G Sanchez, Micah J Ferrell, Alexandra E Chirakos, Kathleen R Nicholson, Robert B Abramovitch, Matthew M Champion, Patricia A Champion
EspM Is a Conserved Transcription Factor That Regulates Gene Expression in Response to the ESX-1 System. mBio 11 (1) (2020)
Huiqing Zheng, John T Williams, Bilal Aleiwi, Edmund Ellsworth, Robert B Abramovitch
Inhibiting Mycobacterium tuberculosis DosRST Signaling by Targeting Response Regulator DNA Binding and Sensor Kinase Heme. ACS chemical biology 15 (1) (2019)
Paulo A M Carneiro, Taynara N Pasquatti, Haruo Takatani, Martin J Zumárraga, Maria J Marfil, Christian Barnard, Scott D Fitzgerald, Robert B Abramovitch, Flábio R Araujo, John Baligwamunsi Kaneene
Molecular characterization of Mycobacterium bovis infection in cattle and buffalo in Amazon Region, Brazil. Veterinary medicine and science 6 (1) (2019)
John T Williams, Elizabeth R Haiderer, Garry B Coulson, Kayla N Conner, Edmund Ellsworth, Chao Chen, Nadine Alvarez-Cabrera, Wei Li, Mary Jackson, Thomas Dick, Robert B Abramovitch
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance. Antimicrobial agents and chemotherapy 63 (10) (2019)
Albert Byungyun Jeon, David F Ackart, Wei Li, Mary Jackson, Roberta J Melander, Christian Melander, Robert B Abramovitch, Adam J Chicco, Randall J Basaraba, Andrés Obregón-Henao
2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain. Scientific reports 9 (1) (2019)
Jacob J Baker, Robert B Abramovitch
Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest. Scientific reports 8 (1) (2018)
Robert B Abramovitch
Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development. IUBMB life 70 (9) (2018)
Huiqing Zheng, John T Williams, Garry B Coulson, Elizabeth R Haiderer, Robert B Abramovitch
HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter. Antimicrobial agents and chemotherapy 62 (7) (2018)
Rachel E Bosserman, Tiffany T Nguyen, Kevin G Sanchez, Alexandra E Chirakos, Micah J Ferrell, Cristal R Thompson, Matthew M Champion, Robert B Abramovitch, Patricia A Champion
WhiB6 regulation of ESX-1 gene expression is controlled by a negative feedback loop in Mycobacterium marinum. Proceedings of the National Academy of Sciences of the United States of America 114 (50) (2017)

Robert B Abramovitch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert B Abramovitch